Navigation Links
Sonic Innovations Announces Results for Fourth Quarter and Full Year 2007
Date:2/5/2008

" as defined under securities laws. Actual results may differ materially and adversely from those described herein depending on a number of factors including, but not limited to, the following risks: we face aggressive competition in our business; acquisitions could be difficult to integrate and disrupt our current business and therefore may harm our operating results; we may poorly operate newly acquired businesses; we may lose a large customer or suffer a reduction in orders from a large customer; we must have innovative, technologically superior products to compete effectively; our products, due to their complexity, may contain errors or defects that are only discovered after sales by our customers, thus harming our reputation and business; we may have issues with intellectual property; and we have important international operations, particularly in Germany and Australia, which expose us to a variety of risks including government reimbursement, that could impact sales and operating results. For additional information regarding the risks inherent in our business, please see "Factors That May Affect Future Performance" included in our Annual Report on Form 10-K for the year ended December 31, 2006, as filed with the Securities and Exchange Commission.

This release contains a non-GAAP financial measure ("EBITDA"). We believe the inclusion of such a non-GAAP financial measure improves the transparency of our disclosure. We have provided a reconciliation of this non-GAAP financial measure to the most directly comparable GAAP measure.

We undertake no obligation to revise our forward-looking statements to reflect events or circumstances after the date hereof as a result of new information, future events or otherwise.

The Company will host a teleconference call in connection with this release on Tuesday, February 5, 2008 at 3:00 p.m. Mountain Time (5:00 p.m. Eastern Time).

To participate in the conference call, please call toll free (800) 291-
'/>"/>

SOURCE Sonic Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Sonic Foundry to Host Wisconsin Lt. Governor Lawton in Raising Awareness for National Depression Screening Day
2. Access Innovations Provides Support Services for Agis Network
3. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
4. Prize for Cutting-Edge Laser Innovations
5. Health Literacy Innovations Releases New Survey on Medicaid Health Literacy Standards
6. Cleveland Clinic Unveils Top 10 Medical Innovations For 2008
7. Inverness Medical Innovations Acquires Bio-Stat Healthcare Group
8. Lumenis(R) Introduces the Newest Innovations in Fractional CO2 Laser Skin Therapy
9. Young Innovations, Inc. Provides Third Quarter Conference Call Details
10. Fenwal Signs Development, Distribution and Licensing Agreement With Data Innovations, Inc.
11. Young Innovations, Inc. Announces Results for the Third Quarter Ended September 30, 2007 and Declares Quarterly Dividend

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...SHINGTON, Nov. 8 The fo...tor, Operation Rescue Insurrecta Nex. ,, Mr. T...ve been fighting to keep child-killing by abortion... Terry states: "This is a great first step to vict...have a lot of fighting ahead of us. Our rejoicing ...
(Date:11/8/2009)...LLYWOOD, Calif., Nov. 8 ...on of Babies luncheon to recognize prominent indiv...dren and who are role models for March of Dimes co... of the March of Dimes November Prematurity Awaren... were urged to join the fight for preemies! ,, ...
(Date:11/7/2009)...USTON, Nov. 7 The Ameri...sa James, Director of Health at the Family Violenc...shed Service today at its semi-annual policy-makin... is the highest honor the AMA House of Delegates b...//www.newscom.com/cgi-bin/prnh/20081209/AMALOGO ...
(Date:11/7/2009)...SHINGTON, Nov. 7 With t...antichoice extremists are holding the entire bill ... are demanding that the bill go far beyond the sta...orporated into the original bill. In an outrageou...y Saturday afternoon, antichoice Democrats are dem...
(Date:11/7/2009)...ON, Nov. 7 Americans United for Life Action endor...pak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smi... money from going to abortion in health care refor... and CEO Dr. Charmaine Yoest said, "Americans Unit...lsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Ame...
Breaking Medicine News(10 mins):Health News:Hollywood Stars Joined in a Celebration of Babies 2Health News:Hollywood Stars Joined in a Celebration of Babies 3Health News:AMA Honors Family Violence Prevention Expert 2Health News:Americans United for Life Action Endorses a Vote for the Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amendment and Sends Score Letter to House Members 2
...rchers at the Monash Institute of Medical Research...nfrared spectroscopy, which allowed scientists// t... it was the first of its kind in Australia, helped...esearch (MIMR) are carrying out studies to underst...
...tists at the University of Bristol have recommende...epaired by bioengineered tissue implants //without...e maturation of cartilage implanted with engineere...ered cartilage implanted in injured and osteoarthr...
...ar-old Indian boy, Santosh Baniya whose parents we...e of the stigma associated with the disease//. ...fter he set himself on fire in Ahmedabad last week...urviving his parents as well as being ostracised o...
...ding to a research conducted by Stephanie Chiuve i...educes the risk of heart ailments//. U.S. rese...pressure and cholesterol can benefit if they alter...nking and smoking habits. But it is good news ...
...ew Zealand Winegrowers are affected by the type 3 ...and quality of grapevines//. But most of the w...ine which are tested vines and are free from the v...d ongoing management and detection. Mr Manson said...
...yers in British Columbia (B.C) are bearing the med... the province for health services//. Government o...lem. Health Minister, George Abbott of B.C. ...is prompting health authorities to look at novel w...
Other Medicine News:Health News:Preterm Babies Benefited from a New NI Spectroscopy 2Health News:Engineered Tissue Implants benefited Knee Injured patients 2
(Date:11/7/2009)... BEACH, Fla., Nov. 7 Patients repo... an effective therapy in treating acute swelling a...rious genetic disorder, according to data presente...sthma & Immunology (ACAAI) Annual Meeting. The...nts conducted in parallel with the ongoing, prospe...
(Date:11/6/2009)...LL, Wash., Nov. 6 SCOLR ...l results for the three and nine months ended Sept...harma,s President and CEO, said, "We continue to a...r ibuprofen formulation. Several potential partner...rsonnel and external resources as they evaluate th...
(Date:11/6/2009)...OUIS, Nov. 6 Recession i...depress sales for Allied Healthcare Products in th...er 30, 2009. ,, Sales declines pushed Allied in...uarter was about $745,000, or negative 9 cents per...of about $208,000, or 3 cents per share. ,, Sa...
Breaking Medicine Technology:Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 3SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 2SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 3SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 4SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 5SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 6SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 7SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 8SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 9Recession Continues to Depress Sales at Allied Healthcare Products 2Recession Continues to Depress Sales at Allied Healthcare Products 3Recession Continues to Depress Sales at Allied Healthcare Products 4Recession Continues to Depress Sales at Allied Healthcare Products 5Recession Continues to Depress Sales at Allied Healthcare Products 6Discovering soybean plants resistant to aphids and a new aphid 9530 1Discovering soybean plants resistant to aphids and a new aphid 9530 2Discovering soybean plants resistant to aphids and a new aphid 9530 3Discovering soybean plants resistant to aphids and a new aphid 9530 4PLUS Diagnostics Announces Senior Executive Appointments 54089 1PLUS Diagnostics Announces Senior Executive Appointments 54089 2PLUS Diagnostics Announces Senior Executive Appointments 54089 3Vion Pharmaceuticals Announces Oncologic Drugs Advisory Committee Meeting for Onrigin 28TM 29 54086 1Vion Pharmaceuticals Announces Oncologic Drugs Advisory Committee Meeting for Onrigin 28TM 29 54086 2Vion Pharmaceuticals Announces Oncologic Drugs Advisory Committee Meeting for Onrigin 28TM 29 54086 3
... (Zurich), Switzerland, May 24, 2007 - Cytos,Biote... a,placebo-controlled, double-blind combined phase...ndidate for the treatment of,psoriasis and other i...rst-time-in-man clinical trial and included 48 pat...riasis. In a first part,of the study, the safety a...
... Mass.--(BUSINESS WIRE)--May 24, 2007 - ImmunoGen,...that develops targeted,anticancer therapeutics usi...oday announced that clinical findings for three,di...umors are to be,reported at the 43rd American Soci...take place June 1-5, 2007 in Chicago, IL., Trastuz...
Other Medicine Technology:Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for,the Treatment of Psoriasis 2Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for,the Treatment of Psoriasis 3Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for,the Treatment of Psoriasis 4ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds,for Solid Tumors Are to be Reported at ASCO 2ImmunoGen, Inc. Announces Clinical Findings for Three TAP Compounds,for Solid Tumors Are to be Reported at ASCO 3
Agarose, ultra high resolution, Molecular Biology Grade
AGAROSE I (Molecular Biology Grade)
Agarose, 500g
Agarose NA
Medicine Products: